Abstract
“Diabetes management” is a collective word given to various plans and measures taken in order to maintain glucose homeostasis. Hyperglycemia is one of the socioeconomic problems that has become prevalent globally. Lifestyle modifications and the lack of physical activities lead to the development of a hyperglycemic condition termed diabetes mellitus. This disorder is associated with comorbidities such as retinopathy, nephropathy, neuropathy, and cardiovascular diseases. Thus, the management of this disorder has become a hectic event. The era of insulin discovery lighted up the path for diabetes management. The pre-insulin discovery period recorded a number of mortality cases due to diabetes. However, the discovery of insulin reduced the mortality cases and extended patient lifetimes. Yet strategies in diabetes management and insulin administration were painful. In the last few decades, a number of treatment options and strategies were made to implement pain-free diabetes management. Many innovative user-friendly methods for insulin administration are being made to comfort users. The innovations made in the mode of administration and technological development paved the way for the introduction of pain-free methods for insulin administration, like microneedle, transdermal patches, chemical permeation enhancers, sonophoresis, iontophoresis, electroporation, and vesicle formation. This chapter focuses on the transformation of painful strategies in diabetes management for the pain-free, blissful management of diabetes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal, V., Reddy, I., & Khan, M. (2000). Oral delivery of proteins: Effect of chicken and duck ovomucoid on the stability of insulin in the presence ofα-chymotrypsin and trypsin. Pharmacy and Pharmacology Communications, 6(5), 223–227. https://doi.org/10.1211/146080800128735935
Ahad, A., Raish, M., Bin Jardan, Y., Al-Mohizea, A., & Al-Jenoobi, F. (2021). Delivery of insulin via skin route for the Management of Diabetes Mellitus: Approaches for breaching the obstacles. Pharmaceutics, 13(1), 100. https://doi.org/10.3390/pharmaceutics13010100
Andersen, A., Christiansen, J., Andersen, J., Kreiner, S., & Deckert, T. (1983). Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study. Diabetologia, 25(6), 496–501. https://doi.org/10.1007/bf00284458
Aronson, R. (2012). The role of comfort and discomfort in insulin therapy. Diabetes Technology & Therapeutics, 14(8), 741–747. https://doi.org/10.1089/dia.2012.0038
Arora, S., Agrawal, N., Shanthaiah, D., Verma, A., Singh, S., Patne, S., et al. (2021). Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Primary Care Diabetes, 15(5), 859–864. https://doi.org/10.1016/j.pcd.2021.06.004
Avgerinos, K., Kalaitzidis, G., Malli, A., Kalaitzoglou, D., Myserlis, P., & Lioutas, V. (2018). Intranasal insulin in Alzheimer’s dementia or mild cognitive impairment: A systematic review. Journal of Neurology, 265(7), 1497–1510. https://doi.org/10.1007/s00415-018-8768-0
Bahman, F., Greish, K., & Taurin, S. (2019). Nanotechnology in insulin delivery for Management of Diabetes. Pharmaceutical Nanotechnology, 7(2), 113–128. https://doi.org/10.2174/2211738507666190321110721
Blanco, M., Hernández, M., Strauss, K., & Amaya, M. (2013). Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Sinical & Metabolism, 39(5), 445–453. https://doi.org/10.1016/j.diabet.2013.05.006
Bliss, M. (1982). The discovery of insulin. The University of Chicago Press.
Bolli, G. B., Di Marchi, R. D., Park, G. D., Pramming, S., & Koivisto, V. A. (1999). Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia, 42(10), 1151–1167. https://doi.org/10.1007/s001250051286
Boucaud, A., Garrigue, M., Machet, L., Vaillant, L., & Patat, F. (2002). Effect of sonication parameters on transdermal delivery of insulin to hairless rats. Journal of Controlled Release, 81(1–2), 113–119. https://doi.org/10.1016/s0168-3659(02)00054-8
Candrilli, S., Davis, K., Kan, H., Lucero, M., & Rousculp, M. (2007). Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Journal of Diabetes and its Complications, 21(5), 306–314. https://doi.org/10.1016/j.jdiacomp.2006.08.002
Cernea, S., & Raz, I. (2020). Insulin therapy: Future perspectives. American Journal of Therapeutics, 27(1), e121–e132. https://doi.org/10.1097/mjt.0000000000001076
Chaluvaraju, K., Niranjan, M., Manjuthej, T., Zaranappa, T., & Mane, K. (2012). Review of insulin and its analogues in diabetes mellitus. Journal Of Basic And Clinical Pharmacy, 3(2), 283. https://doi.org/10.4103/0976-0105.103822
Chen, M., Ling, M., & Kusuma, S. (2015). Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin. Acta Biomaterialia, 24, 106–116. https://doi.org/10.1016/j.actbio.2015.06.021
Denet, A., Vanbever, R., & Préat, V. (2004). Skin electroporation for transdermal and topical delivery. Advanced Drug Delivery Reviews, 56(5), 659–674. https://doi.org/10.1016/j.addr.2003.10.027
Deshpande, A., Harris-Hayes, M., & Schootman, M. (2008). Epidemiology of diabetes and diabetes-related complications. Physical Therapy, 88(11), 1254–1264. https://doi.org/10.2522/ptj.20080020
FDA News Release: FDA approves Afrezza to treat diabetes. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm403122.htm
Feiszthuber, H., Bhatnagar, S., Gyöngy, M., & Coussios, C. (2015). Cavitation-enhanced delivery of insulin in agar and porcine models of human skin. Physics in Medicine and Biology, 60(6), 2421–2434. https://doi.org/10.1088/0031-9155/60/6/2421
Fox, C. (2004). Trends in cardiovascular complications of diabetes. JAMA, 292(20), 2495. https://doi.org/10.1001/jama.292.20.2495
Frias, P., & Frias, J. (2017). New basal insulins: A clinical perspective of their use in the treatment of type 2 diabetes and novel treatment options beyond basal insulin. Current Diabetes Reports, 17(10), 91. https://doi.org/10.1007/s11892-017-0926-8
Fujikura, J., Fujimoto, M., Yasue, S., Noguchi, M., Masuzaki, H., Hosoda, K., et al. (2005). Insulin-induced Lipohypertrophy: Report of a case with histopathology. Endocrine Journal, 52(5), 623–628. https://doi.org/10.1507/endocrj.52.623
Gaddam, M., Singh, A., Jain, N., Avanthika, C., Jhaveri, S., De la Hoz, I., et al. (2021). A comprehensive review of intranasal insulin and its effect on the cognitive function of diabetics. Cureus., 13(8), e17219. https://doi.org/10.7759/cureus.17219
Garg, S., Rewers, A., & Akturk, H. (2018). Ever-increasing insulin-requiring patients globally. Diabetes Technology & Therapeutics, 20(S2), S2-1-S2-4. https://doi.org/10.1089/dia.2018.0101
Goldberg, T., & Wong, E. (2015). Afrezza (insulin human) inhalation powder: A new inhaled insulin for the management of Type-1 or Type-2 diabetes mellitus. P & T: A Peer-Reviewed Journal for Formulary Management, 40(11), 735–741.
Gradel, A., Porsgaard, T., Lykkesfeldt, J., Seested, T., Gram-Nielsen, S., Kristensen, N., & Refsgaard, H. (2018). Factors affecting the absorption of subcutaneously administered insulin: Effect on variability. Journal of Diabetes Research, 2018, 1–17. https://doi.org/10.1155/2018/1205121
Hanson, P., Pandit, M., Menon, V., Roberts, S., & Barber, T. (2014). Painful fat necrosis resulting from insulin injections. Endocrinology, Diabetes & Metabolism Case Reports, 2014, 140073. https://doi.org/10.1530/edm-14-0073
Harris, R., & Leininger, L. (1993). Preventive care in rural primary care practice. Cancer, 72(S3), 1113–1118. https://doi.org/10.1002/1097-0142(19930801)72:3+<1113::aid-cncr2820721328>3.0.co;2-a
Hinchcliffe, M., & Illum, L. (1999). Intranasal insulin delivery and therapy. Advanced Drug Delivery Reviews, 35(2–3), 199–234. https://doi.org/10.1016/s0169-409x(98)00073-8
Hoffman, A., & Ziv, E. (1997). Pharmacokinetic considerations of new insulin formulations and routes of administration. Clinical Pharmacokinetics, 33(4), 285–301. https://doi.org/10.2165/00003088-199733040-00004
Howey, D., Bowsher, R., Brunelle, R., & Woodworth, J. (1994). [Lys(B28), pro(B29)]-human insulin: A rapidly absorbed analogue of human insulin. Diabetes, 43(3), 396–402. https://doi.org/10.2337/diab.43.3.396
Hultström, M., Roxhed, N., & Nordquist, L. (2014). Intradermal insulin delivery. Journal of Diabetes Science and Technology, 8(3), 453–457. https://doi.org/10.1177/1932296814530060
International Diabetes Federation. (2019). Diabetes atlas (9th ed.). International Diabetes Federation.
Jabbari, N., Asghari, M. H., Ahmadian, H., & Mikaili, P. (2015). Developing a commercial air ultrasonic ceramic transducer to transdermal insulin delivery. Journal of Medical Signals and Sensors, 5(2), 117–122.
Jin, X., Zhu, D., Chen, B., Ashfaq, M., & Guo, X. (2018). Insulin delivery systems combined with microneedle technology. Advanced Drug Delivery Reviews, 127, 119–137. https://doi.org/10.1016/j.addr.2018.03.011
Karamitsos, D. (2011). The story of insulin discovery. Diabetes Research and Clinical Practice, 93, S2–S8. https://doi.org/10.1016/s0168-8227(11)70007-9
Karnoosh-Yamchi, J., Mobasseri, M., Akbarzadeh, A., Davaran, S., Ostad-Rahimi, A., Hamishehkar, H., & et al. (2022). Preparation of pH sensitive insulin-loaded nano hydrogels and evaluation of insulin releasing in different pH conditions. Retrieved 2 July 2022, from.
Khafagy, el-S., Morishita, M., Onuki, Y., & Takayama, K. (2007). Current challenges in non-invasive insulin delivery systems: A comparative review. Advanced Drug Delivery Reviews, 59(15), 1521–1546. https://doi.org/10.1016/j.addr.2007.08.019
King, M., Badea, I., Solomon, J., Kumar, P., Gaspar, K., & Foldvari, M. (2002). Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. Diabetes Technology & Therapeutics, 4(4), 479–488. https://doi.org/10.1089/152091502760306562
King, M., Michel, D., & Foldvari, M. (2003). Evidence for lymphatic transport of insulin by topically applied biphasic vesicles. Journal of Pharmacy and Pharmacology, 55(10), 1339–1344. https://doi.org/10.1211/0022357021918
Kleiner, I. (1919). The action of intravenous injections of pancreas emulsions in experimental diabetes. Journal of Biological Chemistry, 40(1), 153–170. https://doi.org/10.1016/s0021-9258(18)87274-x
Kochba, E., Levin, Y., Raz, I., & Cahn, A. (2016). Improved insulin pharmacokinetics using a novel microneedle device for intradermal delivery in patients with type 2 diabetes. Diabetes Technology & Therapeutics, 18(9), 525–531. https://doi.org/10.1089/dia.2016.0156
Kurtzhals, P. (2004). Engineering predictability and protraction in a basal insulin analogue: The pharmacology of insulin detemir. International Journal of Obesity, 28(S2), S23–S28. https://doi.org/10.1038/sj.ijo.0802746
Lavon, I., & Kost, J. (2004). Ultrasound and transdermal drug delivery. Drug Discovery Today, 9(15), 670–676. https://doi.org/10.1016/s1359-6446(04)03170-8
Lee, B., & Adair, F. (1920). Traumatic fat necrosis of the female breast and its differentiation from carcinoma. Annals of Surgery, 72(2), 188–195. https://doi.org/10.1097/00000658-192008000-00011
Li, Y., Quan, Y., Zang, L., Jin, M., Kamiyama, F., Katsumi, H., et al. (2008). Transdermal delivery of insulin using trypsin as a biochemical enhancer. Biological and Pharmaceutical Bulletin, 31(8), 1574–1579. https://doi.org/10.1248/bpb.31.1574
Lindholm, A., McEwen, J., & Riis, A. (1999). Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care, 22(5), 801–805. https://doi.org/10.2337/diacare.22.5.801
Ling, M. H., & Chen, M. C. (2013). Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. Acta Biomaterialia, 9(11), 8952–8961. https://doi.org/10.1016/j.actbio.2013.06.029
Mane, K., Chaluvaraju, K., Niranjan, M., Zaranappa, T., & Manjuthej, T. (2012). Review of insulin and its analogues in diabetes mellitus. Journal of Basic and Clinical Pharmacy, 3(2), 283–293. https://doi.org/10.4103/0976-0105.103822
Marwah, H., Garg, T., Rath, G., & Goyal, A. K. (2016). Development of transferosomal gel for trans-dermal delivery of insulin using iodine complex. Drug Delivery, 23(5), 1636–1644. https://doi.org/10.3109/10717544.2016.1155243
Marwood, S. F. (2022). Diabetes mellitus--some reflections. PubMed. Retrieved 2 July 2022, from https://pubmed.ncbi.nlm.nih.gov/4574717/.
Matsumoto, A., Tanaka, M., Matsumoto, H., Ochi, K., Moro-oka, Y., Kuwata, H., et al. (2017). Synthetic “smart gel” provides glucose-responsive insulin delivery in diabetic mice. Science Advances, 3(11), eaaq0723. https://doi.org/10.1126/sciadv.aaq0723
Mayer, J., Zhang, F., & DiMarchi, R. (2007). Insulin structure and function. Biopolymers, 88(5), 687–713. https://doi.org/10.1002/bip.20734
Mazur, A. (2011). Why were “starvation diets” promoted for diabetes in the pre-insulin period? Nutrition Journal, 10(1), 23. https://doi.org/10.1186/1475-2891-10-23
Mbaye, G., Ndiaye, A., Diouf, L. A., Diallo, A. S., Diedhiou, A., Sene, M., Mbodj, M., Thioune, O., Dieye, A. M., Diop, I., Cisse, A., & Diarra, M. (2009). Developpement d’une matrice ethylcellulose/eudragit pour la liberation controlee et continue de l’insuline [development of Ethylcellulose/Eudragit matrix for controlled and continuous release of insulin]. Le Mali Medical, 24(3), 11–16.
Mesiha, M., Plakogiannis, F., & Vejosoth, S. (1994). Enhanced oral absorption of insulin from desolvated fatty acid-sodium glycocholate emulsions. International Journal of Pharmaceutics, 111(3), 213–216. https://doi.org/10.1016/0378-5173(94)90343-3
Mohammad, E., Elshemey, W., Elsayed, A., & Abd-Elghany, A. (2016). Electroporation parameters for successful transdermal delivery of insulin. American Journal of Therapeutics, 23(6), e1560–e1567. https://doi.org/10.1097/mjt.0000000000000198
Mohanty, R. (2017). Inhaled insulin - current direction of insulin research. Journal of Clinical and Diagnostic Research, 11(4), OE01–OE02. https://doi.org/10.7860/jcdr/2017/23626.9732
Murlin, J., & Kramer, B. (1913). The influence of pancreatic and duodenal extracts on the glycosuria and the respiratory metabolism of depancreatized dogs. Experimental Biology and Medicine, 10(5), 171–173. https://doi.org/10.3181/00379727-10-108
Ogiso, T., Nishioka, S., & Iwaki, M. (1996). Dissociation of insulin oligomers and enhancement of percutaneous absorption of insulin. Biological & Pharmaceutical Bulletin, 19(8), 1049–1054. https://doi.org/10.1248/bpb.19.1049
Oubré, A., Carlson, T., King, S., & Reaven, G. (1997). From plant to patient: An ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia, 40(5), 614–617. https://doi.org/10.1007/s001250050724
Pagneux, Q., Ye, R., Chengnan, L., Barras, A., Hennuyer, N., Staels, B., et al. (2020). Electrothermal patches driving the transdermal delivery of insulin. Nanoscale Horizons, 5(4), 663–670. https://doi.org/10.1039/c9nh00576e
Park, D., Park, H., Seo, J., & Lee, S. (2014). Sonophoresis in transdermal drug deliverys. Ultrasonics, 54(1), 56–65. https://doi.org/10.1016/j.ultras.2013.07.007
Peyrot, M., & Rubin, R. (2006). Resistance to insulin therapy among patients and providers: Results of the cross-national diabetes Attitudes, wishes, and needs (DAWN) study. Diabetes Care, 29(4), 953–954. https://doi.org/10.2337/diacare.29.04.06.dc05-0053
Pharmaceutical Processing World. (2022). FDA approves first ever inhaled insulin combination product for treatment of diabetes - pharmaceutical processing world. [online] Available at: <https://www.pharmaceuticalprocessingworld.com/fda-approves-first-ever-inhaled-insulin-combination-product-for-treatment-of-diabetes/> [Accessed 28 January 2022].
Pliquett, U., & Weaver, J. C. (2007). Feasibility of an electrode-reservoir device for transdermal drug delivery by noninvasive skin electroporation. IEEE Transactions on Bio-Medical Engineering, 54(3), 536–538. https://doi.org/10.1109/TBME.2006.886828
Prausnitz, M. (1996). The effects of electric current applied to skin: A review for transdermal drug delivery. Advanced Drug Delivery Reviews, 18(3), 395–425. https://doi.org/10.1016/0169-409x(95)00081-h
Prausnitz, M., & Langer, R. (2008). Transdermal drug delivery. Nature Biotechnology, 26(11), 1261–1268. https://doi.org/10.1038/nbt.1504
Qaid, M., & Abdelrahman, M. (2016). Role of insulin and other related hormones in energy metabolism—a review. Cogent Food & Agriculture, 2, 1. https://doi.org/10.1080/23311932.2016.1267691
Qiu, Y., Qin, G., Zhang, S., Wu, Y., Xu, B., & Gao, Y. (2012). Novel lyophilized hydrogel patches for convenient and effective administration of microneedle-mediated insulin delivery. International Journal of Pharmaceutics, 437(1–2), 51–56. https://doi.org/10.1016/j.ijpharm.2012.07.035
Quianzon, C., & Cheikh, I. (2022). History of insulin. Retrieved 28 January 2022, from.
Rai, S., Pandey, V., & Rai, G. (2017). Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: The state of the art. Nano Reviews & Experiments, 8(1), 1325708. https://doi.org/10.1080/20022727.2017.1325708
Rambaran, R. N., & Serpell, L. C. (2008). Amyloid fibrils: Abnormal protein assembly. Prion, 2(3), 112–117. https://doi.org/10.4161/pri.2.3.7488
Rastogi, R., Anand, S., Dinda, A., & Koul, V. (2010). Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin. Drug Development and Industrial Pharmacy, 36(8), 993–1004. https://doi.org/10.3109/03639041003682012
Rastogi, S., & Singh, J. (2005). Effect of chemical penetration enhancer and iontophoresis on the in vitro percutaneous absorption enhancement of insulin through porcine epidermis. Pharmaceutical Development and Technology, 10(1), 97–104. https://doi.org/10.1081/pdt-200049679
Reiber, G., Lipsky, B., & Gibbons, G. (1998). The burden of diabetic foot ulcers. The American Journal of Surgery, 176(2), 5S–10S. https://doi.org/10.1016/s0002-9610(98)00181-0
Roach, P. (2008). New insulin analogues and routes of delivery. Clinical Pharmacokinetics, 47(9), 595–610. https://doi.org/10.2165/00003088-200847090-00003
Sakloetsakun, D., Dünnhaupt, S., Barthelmes, J., Perera, G., & Bernkop-Schnürch, A. (2013). Combining two technologies: Multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration. International Journal of Biological Macromolecules, 61, 363–372. https://doi.org/10.1016/j.ijbiomac.2013.08.002
Sapra, A., & Bhandari, P. (2022). Diabetes Mellitus. Ncbi.nlm.nih.gov. Retrieved 2 July 2022, from https://www.ncbi.nlm.nih.gov/books/NBK551501/.
Schlicher, R., Radhakrishna, H., Tolentino, T., Apkarian, R., Zarnitsyn, V., & Prausnitz, M. (2006). Mechanism of intracellular delivery by acoustic cavitation. Ultrasound In Medicine & Biology, 32(6), 915–924. https://doi.org/10.1016/j.ultrasmedbio.2006.02.1416
Scott, E. (1912). On the influence of intravenous injections of an extract of the pancreas on experimental pancreatic diabetes. American Journal Of Physiology-Legacy Content, 29(3), 306–310. https://doi.org/10.1152/ajplegacy.1912.29.3.306
Shah, R., Shah, V., Patel, M., & Maahs, D. (2016). Insulin delivery methods: Past, present and future. International Journal Of Pharmaceutical Investigation, 6(1), 1. https://doi.org/10.4103/2230-973x.176456
Shilo, M., Berenstein, P., Dreifuss, T., Nash, Y., Goldsmith, G., Kazimirsky, G., et al. (2015). Insulin-coated gold nanoparticles as a new concept for personalized and adjustable glucose regulation. Nanoscale, 7(48), 20489–20496. https://doi.org/10.1039/c5nr04881h
Thevis, M., Thomas, A., & Schänzer, W. (2009). Insulin. Handbook of Experimental Pharmacology, (195), 209–226. https://doi.org/10.1007/978-3-540-79088-4_10
Tsadik, A. G., Atey, T. M., Nedi, T., Fantahun, B., & Feyissa, M. (2018). Effect of insulin-induced lipodystrophy on glycemic control among children and adolescents with diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Journal of Diabetes Research, 2018, 4910962. https://doi.org/10.1155/2018/4910962
van Munster, H., PM van de Sande, C., Voorhoeve, P., & van Alfen-van der Velden, J. (2014). Dermatological complications of insulin therapy in children with type 1 diabetes. European Diabetes Nursing, 11(3), 79–84. https://doi.org/10.1002/edn.255
Weiss, M., Steiner, D. F., & Philipson, L. H. Insulin Biosynthesis, Secretion, Structure, and Structure-Activity Relationships. [Updated 2014 Feb 1]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279029/
Wong, C., Al-Salami, H., & Dass, C. (2018). Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin. International Journal of Pharmaceutics, 537(1–2), 223–244. https://doi.org/10.1016/j.ijpharm.2017.12.036
Wong, C., Martinez, J., & Dass, C. (2016). Oral delivery of insulin for treatment of diabetes: Status quo, challenges and opportunities. Journal of Pharmacy and Pharmacology, 68(9), 1093–1108. https://doi.org/10.1111/jphp.12607
Wu, Y., Gao, Y., Qin, G., Zhang, S., Qiu, Y., Li, F., & Xu, B. (2010). Sustained release of insulin through skin by intradermal microdelivery system. Biomedical Microdevices, 12(4), 665–671. https://doi.org/10.1007/s10544-010-9419-0
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (2022). Retrieved 2 July 2022, from
Yaturu, S. (2013). Insulin therapies: Current and future trends at dawn. World Journal of Diabetes, 4(1), 1. https://doi.org/10.4239/wjd.v4.i1.1
Yerramsetty, K., Rachakonda, V., Neely, B., Madihally, S., & Gasem, K. (2010). Effect of different enhancers on the transdermal permeation of insulin analog. International Journal of Pharmaceutics, 398(1–2), 83–92. https://doi.org/10.1016/j.ijpharm.2010.07.029
Yu, F., Li, Y., Liu, C., Chen, Q., Wang, G., Guo, W., & et al. (2022). Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Retrieved 2 July 2022, from.
Zhang, T., Tang, J., Fei, X., Li, Y., Song, Y., Qian, Z., & Peng, Q. (2021). Can nanoparticles and nano–protein interactions bring a bright future for insulin delivery? Acta Pharmaceutica Sinica B, 11(3), 651–667. https://doi.org/10.1016/j.apsb.2020.08.016
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ponnusamy, B., Rajagopal, P., Mukherjee, R., Panneerselvam, S., Jayaraman, S. (2023). Diabetes Management: From “Painful” Pricks to “Pain-Free” Bliss. In: Noor, R. (eds) Advances in Diabetes Research and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-0027-3_9
Download citation
DOI: https://doi.org/10.1007/978-981-19-0027-3_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-0026-6
Online ISBN: 978-981-19-0027-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)